As of the latest SEC filings, Immunovant, Inc. (IMVT) is held by 195 institutional funds. The largest fund shareholder is Fidelity Growth Company Fund (FGCKX), holding an estimated $139,540,992.63 in market value, representing 0.17% of its portfolio.
Funds holding Immunovant, Inc. (IMVT)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- IMVT
- CIK:
- 0001764013
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.17% | $139,540,992.63 | 5,032,131 | Feb 28, 2026 | Apr 24, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $64,517,801.40 | 2,597,335 | Mar 31, 2026 | May 28, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 0.86% | $63,752,555.52 | 2,566,528 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.07% | $49,215,094.56 | 1,981,284 | Mar 31, 2026 | May 28, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.03% | $46,584,016.92 | 1,875,363 | Mar 31, 2026 | May 28, 2026 |
|
FGKFX
Fidelity Growth Company K6 Fund
|
MF | Fidelity | 0.17% | $38,872,413.14 | 1,401,818 | Feb 28, 2026 | Apr 24, 2026 |
|
OTCFX
T. Rowe Price Small-Cap Stock Fund, Inc.
|
MF | T. Rowe Price | 0.46% | $37,185,951.96 | 1,497,019 | Mar 31, 2026 | May 28, 2026 |
|
FCGSX
Fidelity Series Growth Company Fund
|
MF | Fidelity | 0.16% | $33,316,458.07 | 1,201,459 | Feb 28, 2026 | Apr 24, 2026 |
|
VISGX
VANGUARD SMALL-CAP GROWTH INDEX FUND
|
ETF | Vanguard | 0.07% | $26,181,533.88 | 1,054,007 | Mar 31, 2026 | May 28, 2026 |
|
PGOAX
PGIM Jennison Small Company Fund
|
MF | PGIM / Prudential | 0.81% | $25,965,401.04 | 1,045,306 | Mar 31, 2026 | May 27, 2026 |
|
FCNTX
Fidelity Contrafund
|
MF | Fidelity | 0.01% | $23,433,782.76 | 943,389 | Mar 31, 2026 | May 26, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.07% | $21,878,544.26 | 805,988 | Apr 30, 2026 | Jun 26, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.03% | $21,484,811.52 | 864,928 | Mar 31, 2026 | May 28, 2026 |
|
TRSSX
T. Rowe Price Institutional Small-Cap Stock Fund
|
MF | T. Rowe Price | 0.48% | $20,784,969.36 | 836,754 | Mar 31, 2026 | May 28, 2026 |
|
HQH
abrdn Healthcare Investors
|
CEF | abrdn / Aberdeen | 1.57% | $17,866,517.76 | 719,264 | Mar 31, 2026 | May 29, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.14% | $16,537,354.20 | 665,755 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.19% | $15,555,081.24 | 626,211 | Mar 31, 2026 | May 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.03% | $11,115,431.85 | 400,845 | Feb 28, 2026 | Apr 24, 2026 |
|
HQL
abrdn Life Sciences Investors
|
CEF | abrdn / Aberdeen | 1.96% | $10,966,810.32 | 441,498 | Mar 31, 2026 | May 29, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.05% | $10,344,177.36 | 373,032 | Feb 28, 2026 | Apr 24, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.06% | $9,632,847.40 | 347,380 | Feb 28, 2026 | Apr 28, 2026 |
|
PASVX
T. Rowe Price Small-Cap Value Fund, Inc.
|
MF | T. Rowe Price | 0.08% | $7,738,007.76 | 311,514 | Mar 31, 2026 | May 28, 2026 |
|
PHLQX
PGIM Jennison Health Sciences Fund
|
MF | PGIM / Prudential | 0.53% | $7,703,560.38 | 277,806 | Feb 27, 2026 | Apr 23, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.13% | $6,933,082.33 | 250,021 | Feb 28, 2026 | Apr 24, 2026 |
|
VHCIX
VANGUARD HEALTH CARE INDEX FUND
|
ETF | Vanguard | 0.03% | $6,657,307.48 | 240,076 | Feb 28, 2026 | Apr 28, 2026 |
Advertisement (320x50)